drugset / Trial / NCT04933149

Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries

NCT04933149 ↗

Phase 4 Enrolling by invitation 100 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess pre- and postoperative neuropathic pain in patients with traumatic brachial plexus injuries to determine if intraoperative ketamine infusion affect neuropathic pain associated with avulsion injuries of the brachial plexus.

Timeline

Start
2021-12-15
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.1 mg/kg Intravenous
Subject Ketamine Small molecule 0.3 mg/kg Intravenous
Subject Ketamine Small molecule 0.5 mg/kg Intravenous